Table 3 presents a comparison of clinicopathological characteristics between patients with and without SLNM in the training cohort, identifying associations between SLNM risk and factors such as age, tumor location, number of lesions, tumor size, capsular and extraglandular invasions, Ki-67, and P53 (all P < 0.05). Here, TP53 is linked to neoplasm.